Effect of potential therapeutic agents in reducing oxidative stress in pulmonary tissues of recurrent airway obstruction-affected and clinically healthy horses.

This study examines the oxidative stress in lung tissues of horses suffering from recurrent airway obstruction (RAO), also known as “heaves,” compared to healthy horses. It also investigates the effects of several therapeutic agents in reducing said stress. Using tissue samples from euthanized horses, the research team found greater levels of reactive species in RAO-affected horses and that certain drugs, like Pentoxifylline and endothelin antagonists, can effectively reduce these levels.

Objectives and Hypothesis

• The researchers proposed that horses inflicted with RAO would have elevated levels of reactive oxygen and nitrogen species (ROS and RNS) compared to healthy horses.
• They also anticipated that the tested agents – pentoxifylline, pyrrolidine-dithiocarbamate, and endothelin receptor antagonists (BQ123 and BQ788) – would effectively curb these heightened reactive species levels.

Methods

• The study collected arterial and bronchial tissue samples from the diaphragmatic lung lobes of each horse immediately after euthanization.
• These tissues were then used to measure the levels of ROS and RNS, first as control (untreated) cases and again after they were treated with the tested agents.
• The measuring was accomplished using an electron paramagnetic resonance instrument.

Results

• The findings reflected the hypothesis: RAO-affected horses showed significantly higher levels of ROS and RNS in their arterial and bronchial tissues compared to healthy horses.
• Pentoxifylline and the endothelin antagonists helped reduce both ROS and RNS within tissues collected from RAO-affected horses.
• By contrast, these treatment agents did not influence the basal levels of reactive species within healthy horses’ tissues.
• The study also found no variation in ROS and RNS levels between arterial and bronchial tissues.

Conclusions

• Clearly, RAO-affected horses demonstrate greater presence of ROS and RNS than horses without this condition.
• Notably, pentoxifylline and endothelin antagonists effectively lower these heightened ROS and RNS levels in the pulmonary tissues of afflicted horses.
• However, since endothelin fulfills significant physiological roles, any therapeutic use of its antagonists should be considered carefully.
• In conclusion, the research suggests potential uses for pentoxifylline and endothelin antagonists in the treatment of RAO in horses, pending careful administration and considerations of the functions of endothelin in the body.